Conventional dose of fat-Soluble Vitamin — Competitive Intelligence Brief

Conventional dose of fat-Soluble Vitamin (Conventional dose of fat-Soluble Vitamin) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin supplement. Area: Nutritional deficiency / General health.

phase 3 Vitamin supplement Nutritional deficiency / General health Small molecule

Target snapshot

Conventional dose of fat-Soluble Vitamin (Conventional dose of fat-Soluble Vitamin) — First Affiliated Hospital Xi'an Jiaotong University. Fat-soluble vitamins (A, D, E, K) are absorbed in the intestine and distributed to tissues where they serve as cofactors and signaling molecules for essential physiological processes.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Conventional dose of fat-Soluble Vitamin TARGET	Conventional dose of fat-Soluble Vitamin	First Affiliated Hospital Xi'an Jiaotong University	phase 3	Vitamin supplement
ZENTEL and Vitamin A Soft Capsules	ZENTEL and Vitamin A Soft Capsules	Chengdu Maternal and Children's Health Care Hospital	marketed	Anthelmintic + Vitamin supplement	β-tubulin (albendazole component)
i.m. injection of vitamin B12	i.m. injection of vitamin B12	University Hospital, Basel, Switzerland	marketed	Vitamin supplement / Essential nutrient	Methionine synthase, methylmalonyl-CoA mutase
Metformin plus folic acid	Metformin plus folic acid	University Magna Graecia	marketed	Antidiabetic agent with vitamin supplement	AMPK (metformin); folate receptors and methylenetetrahydrofolate reductase (folic acid)
Vitamins E + C	Vitamins E + C	University Hospital, Aker	marketed	Vitamin supplement / Antioxidant combination
Vitamins: Folic acid, B6, B12	Vitamins: Folic acid, B6, B12	Hamilton Health Sciences Corporation	marketed	Vitamin supplement / B-complex
Enalapril/folic acid	Enalapril/folic acid	Shenzhen Ausa Pharmed Co.,Ltd	marketed	ACE inhibitor with vitamin supplement	Angiotensin-converting enzyme (ACE)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin supplement class)

1. Ain Shams University · 1 drug in this class
2. CHU de Quebec-Universite Laval · 1 drug in this class
3. First Affiliated Hospital Xi'an Jiaotong University · 1 drug in this class
4. Fundação Educacional Serra dos Órgãos · 1 drug in this class
5. M.D. Anderson Cancer Center · 1 drug in this class
6. Washington University School of Medicine · 1 drug in this class